MAPT and Alzheimer disease: In this respect, many prior studies have targeted dominant elements of AD pathology such as Aβ production and deposition, tau aggregation, angiogenesis, neuroinflammation, or neurotransmitter deficit.[20] These approaches alone provide insufficient clinical benefits due to the complex inter‐relationships between pathological pathways.